You are here: All Products  > Akeso Says PD-1/VEGF Candidate Out-Performs Keytruda in NSCLC

Akeso Says PD-1/VEGF Candidate Out-Performs Keytruda in NSCLC

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven day.